Mycophenolate mofetil (CellCept®) for psoriasis: A two-center, prospective, open-label clinical trial

Journal of Cutaneous Medicine and Surgery

Volumn 7, Issue 3, 2003, Pages 193-197

  Zhou, Youwen ^a   Rosenthal, Don ^b   Dutz, Jan ^a   Ho, Vincent ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; FEMALE; HUMAN; LEUKOPENIA; MALE; MONOTHERAPY; MULTICENTER STUDY; NAUSEA; OPEN STUDY; ORBIT DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; PSORIASIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PROSPECTIVE STUDIES; PSORIASIS; TREATMENT OUTCOME;

EID: 0037825768     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10227-002-0113-6     Document Type: Article

References (13)

1. Ransom JT. Mechanism of action of mycophenolate mofetil. Ther Drug Monit 1995; 17(6):681-684.
2. Lipsky JJ. Mycophenolate mofetil. Lancet 1996; 348(9038):1357-1359.
3. Kitchin JE, Pomeranz MK, Pak G, et al. Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses. J Am Acad Dermatol 1997; 37(3 Pt 1):445-449.
4. Enk AH, Knop J. Treatment of pemphigus vulgaris with mycophenolate mofetil [letter]. Lancet 1997; 350(9076):494.
5. Zhou Y, Dutz J, Ho V. Mycophenolate mofetil for dermatological diseases. J Cutan Med Surg 2001; 5(3 Suppl):26-29.
6. Dutz J, Ho V. Immunosuppressive agents in skin disorders, a comparative review. Clin Immunother 1996; 5(4):269-293.
7. Abrams JR, Lebwohl MG, Guzzo CA, et al. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J Clin Invest 1999; 103(9):1243-1252.
8. Gottlieb AB, Krueger JG, Khandke L, et al. Role of T cell activation in the pathogenesis of psoriasis. Ann NY Acad Sci 1991; 636:377-379.
9. Federiksson A, Patersonn D. Severe psoriasis: oral therapy with a new retinoid. Dermatologica 1978; 157:238-244.
10. Hoffman-La Roche Ltd. CellCept (mycophenolate mofetil), Immunosuppressant agent. Nutley, NJ: Roche Pharmaceuticals, 1997.
11. Haufs MG, Beissert S, Grabbe S, et al. Psoriasis vulgaris treated successfully with mycophenolate mofetil [see comments]. Br J Dermatol 1998; 138(1):179-181.
12. Nousari HC, Sragovich A, Kimyai-Asadi A, et al. Mycophenolate mofetil in autoimmune and inflammatory skin disorders. J Am Acad Dermatol 1999; 40(2 Pt 1):265-268.
13. Grundmann-Kollmann M, Mooser G, Schraeder PF, et al. Treatment of chronic plaque-stage psoriasis and psoriatic arthritis with mycophenolate mofetil. J Am Acad Dermatol 2000; 42(5 Pt 1):835-837.